July 11, 2012–Given Imaging Ltd. (GIVN) (GIVN) rose to the highest level in six weeks in New York after Japan said it will reimburse patients for use of two of its treatments.
The Israeli maker of swallowable pill-sized cameras for digestive diagnosis added 1.2 percent to $16.98 by 1:48 p.m. in New York, set for the highest level since May 29. The Tel Aviv shares ended little changed at 67.19 shekels, or the equivalent of $16.95.
Japan’s Ministry of Health, Labor and Wellfare has issued reimbursement codes for Given Imaging’s PillCam Patency Capsule and SB video capsule for the 105 million adults in the country, according to a statement today. The Asia Pacific and Japan region accounted for 14 percent of the Yokneam, Israel-based company’s revenue in 2011, and the Europe, Middle East and Africa region encompassed 25 percent of tis sales, according to data compiled by Bloomberg…Read More>>